Adoption of AI for Early Drug Discovery: Challenges and Opportunities for CROs

AI is rapidly moving from experimentation to real-world application in early drug discovery. But where does it truly add value for CROs and what continues to limit broader adoption? |

Raccontata dafiercebiotech.com